Literature DB >> 21113191

Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia.

Y-H Chao, C Tsai, C-T Peng, H-P Wu, C-K Chan, T Weng, K-H Wu.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21113191     DOI： 10.1038/bmt.2010.305

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  16 in total

Review 1.  Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

Authors:  Melania Lo Iacono; Rita Anzalone; Giampiero La Rocca; Elena Baiamonte; Aurelio Maggio; Santina Acuto
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

2.  Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.

Authors:  Hao Daniel Lin; Chui Yee Fong; Arijit Biswas; Mahesh Choolani; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

3.  Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.

Authors:  Daniel Hao Lin; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

Review 4.  The complex pathophysiology of acquired aplastic anaemia.

Authors:  Y Zeng; E Katsanis
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

5.  Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+Foxp3+ regulatory T cells differentiation.

Authors:  Jianzhi Zhao; Jingrong Chen; Feng Huang; Julie Wang; Wenru Su; Jianyao Zhou; Quanyin Qi; Fenglin Cao; Baoqing Sun; Zhongmin Liu; Joseph A Bellanti; Songguo Zheng
Journal:  Am J Transl Res       Date:  2019-12-15       Impact factor: 4.060

6.  CD29 of human umbilical cord mesenchymal stem cells is required for expansion of CD34(+) cells.

Authors:  Y Yang; M Hu; Y Zhang; H Li; Z Miao
Journal:  Cell Prolif       Date:  2014-09-18       Impact factor: 6.831

7.  Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage model.

Authors:  Kuan-Hung Chen; Han-Tan Chai; Kun-Chen Lin; John Y Chiang; Pei-Hsun Sung; Chih-Hung Chen; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

8.  Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Authors:  Clara Bueno; Mar Roldan; Eduardo Anguita; Damia Romero-Moya; Beatriz Martín-Antonio; Michael Rosu-Myles; Consuelo del Cañizo; Francisco Campos; Regina García; Maite Gómez-Casares; Jose Luis Fuster; Manuel Jurado; Mario Delgado; Pablo Menendez
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

9.  Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia.

Authors:  Yuewen Fu; Qian Wang; Jian Zhou; Shengquan Liu; Baijun Fang; Xudong Wei; Yongping Song
Journal:  Int J Hematol       Date:  2013-11-22       Impact factor: 2.490

Review 10.  Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation.

Authors:  Yu-Hua Chao; Han-Ping Wu; Chin-Kan Chan; Chris Tsai; Ching-Tien Peng; Kang-Hsi Wu
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.